Latest news about Caprolactam Chemicals
Caprolactam Chemicals
49.88
-2.62(-4.99%)
Company Performance:
View Company Insights1D-4.99%
1M+7.48%
6M+4.88%
1Y+12.85%
5Y+34.27%
More news about Caprolactam Chemicals
27Jan 26
Caprolactam Chemicals Limited Schedules Board Meeting for February 13, 2026 to Review Q3FY26 Results and Dividend Recommendation
Caprolactam Chemicals Limited has scheduled its Board of Directors meeting for February 13, 2026, at 4:00 PM to consider and approve unaudited financial results for the quarter ended December 31, 2025, and evaluate dividend recommendations on equity shares. The company has implemented trading window restrictions for designated persons and their relatives, effective from January 1, 2026, until 48 hours after the financial results declaration, in compliance with insider trading regulations.
01Dec 25
Shital S. Bhanushali Increases Stake in Caprolactam Chemicals to 7.83%
Shital S. Bhanushali, a promoter of Caprolactam Chemicals Limited, has acquired 5,420 additional shares through an open market purchase. This acquisition has increased Bhanushali's total shareholding to 360,022 shares, representing 7.83% of the company. The transaction was completed on 28.11.2025 and reported in compliance with SEBI regulations.
25Sept 25
Caprolactam Chemicals Shareholders Approve Key Leadership Reappointments and New Auditor
Caprolactam Chemicals' 36th AGM saw shareholders approve several significant appointments. Ms. Zaver Shankarlal Bhanushali was reappointed as Managing Director for a five-year term from August 7, 2025, to August 6, 2030. Mr. Siddharth Shankarlal Bhanushali was reappointed as Whole Time Director and CFO for the same period. M/s. Alpi Nehra and Associates were appointed as Secretarial Auditors for five years. The Bhanushali family maintains strong leadership roles in the company, with Ms. Zaver being Mr. Siddharth's mother.
14Aug 25
Caprolactam Chemicals Reports Q1 FY26 Profit Turnaround and Announces 36th AGM Details
Caprolactam Chemicals Ltd. reported a turnaround in Q1 FY26 with a profit of ₹36.21 lakhs, compared to a loss in the previous quarter. Revenue increased by 59.4% to ₹256.47 lakhs. The company's 36th AGM is scheduled for September 25, 2025, with e-voting from September 20-24. The Board approved the Director's Report for FY25 and appointed scrutinizers for the e-voting process.
Industry Peers
Tata Chemicals
Deepak Fertilisers & Petrochemicals
Gujarat Narmada Valley Fert & Chem
Gujarat Alkalies & Chemicals
TANFAC Industries
GHCL
Chemplast Sanmar
Grauer & Weil
Thirumalai Chemicals
Fischer Medical Ventures
748.90
(-1.08%)
1,318.50
(+1.47%)
514.35
(-1.08%)
702.90
(+0.16%)
2,182.20
(+1.06%)
472.65
(+0.65%)
229.37
(-0.71%)
64.38
(-2.02%)
205.68
(-2.60%)
34.87
(-0.80%)
Get More Market Insights with
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
